Pioneering Healthcare Transformation through AI Innovation Artificial Intelligence (AI) holds immense promise in revolutionizing healthcare by offering innovative solutions that can significantly enhance patient care, operational efficiency, and medical research. MedBright AI (Ticker: MBAI.c or MBAIF for US investors) acknowledges the substantial potential of AI in the healthcare sector, and actively invests in numerous companies engaged in the development of healthcare AI.
Their flagship offering, MedMatrix, utilizes artificial intelligence to predict patient needs and optimize resource allocation in clinics. This integrated system aims to improve clinic revenue, enhance patient satisfaction, and reduce physician burnout, while seamlessly integrating with existing clinical software.
MedMatrix's dynamic matching feature, which matches resources with patient needs, is expected to increase clinic revenues by an average of 10% without increasing costs. By analyzing various data sources, including Clinic EHR Data, Personal Interaction Data, and Facility Resource Data, MedMatrix predicts patient needs, optimizes resource matching, and identifies growth opportunities.
With an estimated $220 billion revenue opportunity in the $2.2 trillion healthcare services market, MedMatrix is positioned as a first mover in this space.
Recently, MBAI welcomed two healthcare providers, Dermatology Institute & Skin Care Center (DISCC) and CareMEDICA, as new beta customers.
CareMEDICA, affiliated with Yale University School of Medicine, has chosen MedMatrix to enhance its clinical operations, expressing enthusiasm about leveraging AI for improved clinical efficiency.
Overall, these partnerships showcase MedBright AI's commitment to advancing healthcare operations through innovative AI solutions.
More here: https://ca.finance.yahoo.com/news/medbright-ai-announces-caremedica-yale-130000496.html
Posted on behalf of MedBright AI Investments Inc.